Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
5.90
+0.04 (0.77%)
Jun 2, 2026, 4:00 PM EDT - Market closed
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $18.91 million as of June 3, 2026. Its market cap has increased by 0.75% in one year.
Market Cap
18.91M
Enterprise Value
-8.67M
1-Year Change
0.75%
Ranking
Category
Stock Price
$5.90
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $18.91M, a decrease of -98.02%. That is a compound annual growth rate of -46.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 18.91M | -49.59% |
| Dec 31, 2025 | 37.51M | 7.08% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CEL-SCI | 21.45M |
| Exicure | 21.23M |
| Curis | 20.93M |
| Tempest Therapeutics | 20.80M |
| AEON Biopharma | 19.73M |
| NewcelX | 18.74M |
| Lipocine | 18.30M |
| Quince Therapeutics | 18.09M |